Literature DB >> 12009503

Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques.

Jack van Horssen1, Johanneke Kleinnijenhuis, Cathy N Maass, Annemieke A M Rensink, Irene Otte-Höller, Guido David, Lambert P W J van den Heuvel, Pieter Wesseling, Robert M W de Waal, Marcel M Verbeek.   

Abstract

Alzheimer's disease (AD) brains are characterized by the presence of senile plaques (SPs), which primarily consist of amyloid beta protein (Abeta). Besides Abeta, several other proteins with the ability to modulate amyloid fibril formation accumulate in SPs, e.g. heparan sulfate proteoglycans (HSPGs). Cerebellar SPs are predominantly of the diffuse type, whereas fibrillar SPs are rarely observed. Furthermore, because of the spatial separation of non-fibrillar and fibrillar SPs in the cerebellum, this brain region provides a model for the study of the association of Abeta-associated factors with various stages of SP formation. In the present study, we performed an immunohistochemical analysis to investigate the expression of the HSPG species agrin, perlecan, glypican-1 and the syndecans 1-3 as well as glycosaminoglycan side-chains in cerebellar SPs. We demonstrated that agrin and glypican-1 were expressed in both non-fibrillar and fibrillar cerebellar SPs, whereas the syndecans were only associated with fibrillar cerebellar SPs. Perlecan expression was absent in all cerebellar SPs. Since fibrillar and non-fibrillar SPs may develop independently in the cerebellum, it is likely that agrin, glypican-1 as well as heparan sulfate glycosaminoglycans may contribute to the formation of both cerebellar plaque types, whereas syndecan only seems to play a role in the generation of cerebellar fibrillar plaques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009503     DOI: 10.1016/s0197-4580(02)00010-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

Review 1.  Amyloid accomplices and enforcers.

Authors:  Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.

Authors:  Paul O'Callaghan; Elina Sandwall; Jin-Ping Li; Hong Yu; Rivka Ravid; Zhi-Zhong Guan; Toin H van Kuppevelt; Lars N G Nilsson; Martin Ingelsson; Bradley T Hyman; Hannu Kalimo; Ulf Lindahl; Lars Lannfelt; Xiao Zhang
Journal:  Brain Pathol       Date:  2008-04-11       Impact factor: 6.508

Review 4.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

Review 5.  Kainic acid-mediated excitotoxicity as a model for neurodegeneration.

Authors:  Qun Wang; Sue Yu; Agnes Simonyi; Grace Y Sun; Albert Y Sun
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

6.  Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.

Authors:  O Kovalchuk Ben-Zaken; I Nissan; S Tzaban; A Taraboulos; E Zcharia; S Matzger; I Shafat; I Vlodavsky; Y Tal
Journal:  Biochem Biophys Res Commun       Date:  2015-07-10       Impact factor: 3.575

7.  Overexpression of heparanase lowers the amyloid burden in amyloid-β precursor protein transgenic mice.

Authors:  Charlotte B Jendresen; Hao Cui; Xiao Zhang; Israel Vlodavsky; Lars N G Nilsson; Jin-Ping Li
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

8.  Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease.

Authors:  Iván Fernández-Vega; Laura Lorente-Gea; Carla Martín; Luis M Quirós
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

9.  Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells.

Authors:  Yuanwei Yan; Liqing Song; Julie Bejoy; Jing Zhao; Takahisa Kanekiyo; Guojun Bu; Yi Zhou; Yan Li
Journal:  Tissue Eng Part A       Date:  2018-02-27       Impact factor: 4.080

10.  Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.

Authors:  Patricia Aguilar-Calvo; Alejandro M Sevillano; Jaidev Bapat; Katrin Soldau; Daniel R Sandoval; Hermann C Altmeppen; Luise Linsenmeier; Donald P Pizzo; Michael D Geschwind; Henry Sanchez; Brian S Appleby; Mark L Cohen; Jiri G Safar; Steven D Edland; Markus Glatzel; K Peter R Nilsson; Jeffrey D Esko; Christina J Sigurdson
Journal:  Acta Neuropathol       Date:  2019-10-31       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.